Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia

E. Emanuele, E. Peros, P. Minoretti, A. D'Angelo, M. N. Piccinni, L. Montagna, D. Geroldi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background and Aim: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hypercholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes in relation to occurrence of CHD events in PH patients. Methods and Results: Lp(a) levels and apo(a) isoforms were determined in 191 PH patients, 83 normocholesterolemic subjects with CHD, and 94 normocholesterolemic controls without CHD. Lp(a) levels were similar in the hypercholesterolemic subjects with (n=100) or without CHD (n=91): 21.4 (range 6.6-59.23) vs 18.5 (range 5.25-57.25) mg/dL (p=NS). Low molecular weight apo(a) isoforms were more prevalent (55%) in the PH patients with CHD, whereas high molecular weight apo(a) isoforms were more prevalent (62.6%) in those without CHD: this difference was significant (p

Original languageEnglish
Pages (from-to)193-199
Number of pages7
JournalNutrition, Metabolism and Cardiovascular Diseases
Volume14
Issue number4
Publication statusPublished - Aug 2004

Fingerprint

Apoprotein(a)
apolipoproteins
hypercholesterolemia
Hypercholesterolemia
polymorphism
Coronary Disease
Lipoprotein(a)
lipoproteins
Protein Isoforms
risk factors
Molecular Weight
molecular weight
coronary disease
cholesterol
Phenotype
phenotype
Serum

Keywords

  • Apolipoprotein(a)
  • Coronary heart disease
  • Genetic markers
  • Lipoprotein(a)
  • Polygenic hypercholesterolemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine (miscellaneous)
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia. / Emanuele, E.; Peros, E.; Minoretti, P.; D'Angelo, A.; Piccinni, M. N.; Montagna, L.; Geroldi, D.

In: Nutrition, Metabolism and Cardiovascular Diseases, Vol. 14, No. 4, 08.2004, p. 193-199.

Research output: Contribution to journalArticle

Emanuele, E, Peros, E, Minoretti, P, D'Angelo, A, Piccinni, MN, Montagna, L & Geroldi, D 2004, 'Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia', Nutrition, Metabolism and Cardiovascular Diseases, vol. 14, no. 4, pp. 193-199.
Emanuele, E. ; Peros, E. ; Minoretti, P. ; D'Angelo, A. ; Piccinni, M. N. ; Montagna, L. ; Geroldi, D. / Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia. In: Nutrition, Metabolism and Cardiovascular Diseases. 2004 ; Vol. 14, No. 4. pp. 193-199.
@article{32a74bbbacd94e31a9ccef5126ea3bdb,
title = "Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia",
abstract = "Background and Aim: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hypercholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes in relation to occurrence of CHD events in PH patients. Methods and Results: Lp(a) levels and apo(a) isoforms were determined in 191 PH patients, 83 normocholesterolemic subjects with CHD, and 94 normocholesterolemic controls without CHD. Lp(a) levels were similar in the hypercholesterolemic subjects with (n=100) or without CHD (n=91): 21.4 (range 6.6-59.23) vs 18.5 (range 5.25-57.25) mg/dL (p=NS). Low molecular weight apo(a) isoforms were more prevalent (55{\%}) in the PH patients with CHD, whereas high molecular weight apo(a) isoforms were more prevalent (62.6{\%}) in those without CHD: this difference was significant (p",
keywords = "Apolipoprotein(a), Coronary heart disease, Genetic markers, Lipoprotein(a), Polygenic hypercholesterolemia",
author = "E. Emanuele and E. Peros and P. Minoretti and A. D'Angelo and Piccinni, {M. N.} and L. Montagna and D. Geroldi",
year = "2004",
month = "8",
language = "English",
volume = "14",
pages = "193--199",
journal = "Nutrition, Metabolism and Cardiovascular Diseases",
issn = "0939-4753",
publisher = "Elsevier B.V.",
number = "4",

}

TY - JOUR

T1 - Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia

AU - Emanuele, E.

AU - Peros, E.

AU - Minoretti, P.

AU - D'Angelo, A.

AU - Piccinni, M. N.

AU - Montagna, L.

AU - Geroldi, D.

PY - 2004/8

Y1 - 2004/8

N2 - Background and Aim: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hypercholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes in relation to occurrence of CHD events in PH patients. Methods and Results: Lp(a) levels and apo(a) isoforms were determined in 191 PH patients, 83 normocholesterolemic subjects with CHD, and 94 normocholesterolemic controls without CHD. Lp(a) levels were similar in the hypercholesterolemic subjects with (n=100) or without CHD (n=91): 21.4 (range 6.6-59.23) vs 18.5 (range 5.25-57.25) mg/dL (p=NS). Low molecular weight apo(a) isoforms were more prevalent (55%) in the PH patients with CHD, whereas high molecular weight apo(a) isoforms were more prevalent (62.6%) in those without CHD: this difference was significant (p

AB - Background and Aim: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hypercholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes in relation to occurrence of CHD events in PH patients. Methods and Results: Lp(a) levels and apo(a) isoforms were determined in 191 PH patients, 83 normocholesterolemic subjects with CHD, and 94 normocholesterolemic controls without CHD. Lp(a) levels were similar in the hypercholesterolemic subjects with (n=100) or without CHD (n=91): 21.4 (range 6.6-59.23) vs 18.5 (range 5.25-57.25) mg/dL (p=NS). Low molecular weight apo(a) isoforms were more prevalent (55%) in the PH patients with CHD, whereas high molecular weight apo(a) isoforms were more prevalent (62.6%) in those without CHD: this difference was significant (p

KW - Apolipoprotein(a)

KW - Coronary heart disease

KW - Genetic markers

KW - Lipoprotein(a)

KW - Polygenic hypercholesterolemia

UR - http://www.scopus.com/inward/record.url?scp=7744225871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7744225871&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 193

EP - 199

JO - Nutrition, Metabolism and Cardiovascular Diseases

JF - Nutrition, Metabolism and Cardiovascular Diseases

SN - 0939-4753

IS - 4

ER -